Unknown Manufacturer
BBIBP-CorV vaccine contains a SARS-CoV-2 strain inactivated inside Vero Cells. Investigation shows this vaccine induces neutralizing antibodies in several mammalian species while also showing protective efficacy with SARS-CoV-2 challenge in rhesus macaques. As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.
BBIBP-CorV vaccine contains a SARS-CoV-2 strain inactivated inside Vero Cells. Investigation shows this vaccine induces neutralizing antibodies in several mammalian species while also showing protective efficacy with SARS-CoV-2 challenge in rhesus macaques. As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
